The securities referenced do not represent all of the securities purchased, sold, or recommended for advisory clients
Disclosures Shin Iries institution has received funding to conduct clinical trials from Novo Nordisk, Eli Lilly and Company, Teijin Pharma, Daiichi Sankyo Company, Takeda Pharmaceutical Company Limited, Sanofi K.K., Nippon Boehringer Ingelheim Co., and AstraZeneca
However, always recommend that your clients consult with a healthcare provider before making major dietary changes, especially when aiming to optimize GLP-1 medication
There is no established cycle length for the blend specifically
Altogether, extrapolating preclinical findings directly to a human setting is premature without further investigations